Asa Smith-Dahle
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 13, 2020
Testicular cancer: improving outcomes with national quality performance indicators.
Journal: BMJ open quality
Published: May 15, 2019
Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 25, 2017
Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.
Journal: British journal of cancer
Published: May 27, 2016
Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.
Journal: British journal of cancer
Published: December 02, 2015
Biomarkers and novel agents in esophago-gastric cancer: are we making progress?
Journal: Expert review of anticancer therapy
Published: August 28, 2015
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial.
Journal: The Lancet. Oncology
Published: June 22, 2014
Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.
Journal: British journal of cancer
Published: May 29, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026